Department of Emergency Medicine and Critical Care, Tokyo Bay Urayasu Ichikawa Medical Center, Chiba, Japan; Center for Clinical Epidemiology, St. Luke's International University, Tokyo, Japan.
Department of Emergency Medicine and Critical Care, Tokyo Bay Urayasu Ichikawa Medical Center, Chiba, Japan; Department of Emergency Medicine, International University of Health and Welfare, Tokyo, Japan.
Am J Emerg Med. 2019 Feb;37(2):241-248. doi: 10.1016/j.ajem.2018.05.037. Epub 2018 May 21.
This study assessed the association between the timing of first epinephrine administration (EA) and the neurological outcomes following out-of-hospital cardiac arrests (OHCAs) with both initial shockable and non-shockable rhythms.
This was a post-hoc analysis of a multicenter prospective cohort study (SOS-KANTO 2012), which registered OHCA patients in the Kanto region of Japan from January 2012 to March 2013. We included consecutive adult OHCA patients who received epinephrine. The primary result included 1-month favorable neurological outcomes defined as cerebral performance category (CPC) 1 or 2. Secondary results included 1-month survival and return of spontaneous circulation (ROSC) after arrival at the hospital. Multivariable logistic regression analysis determined the association between delay per minute of the time from call to first EA in both pre- or in-hospital settings and outcomes.
Of the 16,452 patients, 9344 were eligible for our analyses. In univariable analysis, the delay in EA was associated with decreased favorable neurological outcomes only when the initial rhythm was a non-shockable rhythm. In multivariable analyses, delay in EA was associated with decreased ROSC (adjusted odds ratio [OR] for one minute delay, 0.97; 95% confidence interval [CI], 0.96-0.98) and 1-month survival (adjusted OR, 0.95; 95% CI, 0.92-0.97) when the initial rhythm was a non-shockable rhythm, whereas during a shockable rhythm, delay in EA was not associated with decreased ROSC and 1-month survival.
While assessing the effectiveness of epinephrine for OHCA, we should consider the time-limited effects of epinephrine. Additionally, consideration of early EA based on the pathophysiology is needed.
本研究旨在评估初始可电击节律和初始不可电击节律的院外心脏骤停(OHCA)患者中,首次肾上腺素给药(EA)时间与神经预后之间的关系。
这是一项多中心前瞻性队列研究(SOS-KANTO 2012)的事后分析,该研究于 2012 年 1 月至 2013 年 3 月在日本关东地区登记 OHCA 患者。我们纳入了接受肾上腺素治疗的连续成年 OHCA 患者。主要结果包括 1 个月时的良好神经预后,定义为脑功能分类(CPC)1 或 2 级。次要结果包括 1 个月时的存活率和到达医院后的自主循环恢复(ROSC)。多变量逻辑回归分析确定了从呼叫到首次 EA 的时间每延迟 1 分钟与结果之间的关系,无论在院前或院内环境中。
在 16452 名患者中,有 9344 名患者符合我们的分析条件。在单变量分析中,仅当初始节律为不可电击节律时,EA 的延迟与神经预后不良降低相关。在多变量分析中,当初始节律为不可电击节律时,EA 的延迟与 ROSC 降低相关(调整后的优势比[OR]每延迟 1 分钟为 0.97;95%置信区间[CI]为 0.96-0.98)和 1 个月时的存活率(调整后的 OR,0.95;95%CI,0.92-0.97),而在可电击节律时,EA 的延迟与 ROSC 和 1 个月时的存活率降低无关。
在评估肾上腺素对 OHCA 的有效性时,我们应考虑肾上腺素的限时效应。此外,需要根据病理生理学考虑早期 EA。